Epidemiological Patterns of Chronic Kidney Disease Attributed to Type 2 Diabetes from 1990-2019

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 May 2

PMID 38694939

Authors

Xiaoxiao Ding

Xiang Li

Yun Ye

Jing Jiang

Mengsang Lu

Lv Shao

Affiliations

Soon will be listed here.

Abstract

Background: This study investigates the burden of chronic kidney disease attributed to type 2 diabetes (CKD-T2D) across different geographical locations and time periods from 1990 to 2019. A total of 204 countries and regions are included in the analysis, with consideration given to their socio-demographic indexes (SDI). The aim is to examine both spatial and temporal variations in CKD-T2D burden.

Methods: This research utilized data from the 2019 Global Burden of Diseases Study to evaluate the age-standardized incidence rates (ASIR), Disability-Adjusted Life Years (DALYs), and Estimated Annual Percentage Change (EAPC) associated with CKD-T2D.

Results: Since 1990, there has been a noticeable increase of CKD age-standardized rates due to T2D, with an EAPCs of 0.65 (95% confidence interval [CI]: 0.63 to 0.66) for ASIR and an EAPC of 0.92 (95% CI: 0.8 to 1.05) for age-standardized DALYs rate. Among these regions, Andean Latin America showed a significant increase in CKD-T2D incidence [EAPC: 2.23 (95% CI: 2.11 to 2.34) and North America showed a significant increase in CKD-T2D DALYs [EAPC: 2.73 (95% CI: 2.39 to 3.07)]. The burden was higher in male and increased across all age groups, peaking at 60-79 years. Furthermore, there was a clear correlation between SDI and age-standardized rates, with regions categorized as middle SDI and High SDI experiencing a significant rise in burden.

Conclusion: The global burden of CKD-T2D has significantly risen since 1990, especially among males aged 60-79 years and in regions with middle SDI. It is imperative to implement strategic interventions to effectively address this escalating health challenge.

References

Horlyck-Romanovsky M, Wyka K, Echeverria S, Leung M, Fuster M, Huang T . Foreign-Born Blacks Experience Lower Odds of Obesity but Higher Odds of Diabetes than US-Born Blacks in New York City. J Immigr Minor Health. 2018; 21(1):47-55. DOI: 10.1007/s10903-018-0708-7. View

Mollsten A, Svensson M, Waernbaum I, Berhan Y, Schon S, Nystrom L . Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes. 2010; 59(7):1803-8. PMC: 2889782. DOI: 10.2337/db09-1744. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Kim K, Park S, Cho Y, Kyung Kim S . Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2018; 42(3):224-232. PMC: 6015966. DOI: 10.4093/dmj.2017.0065. View

Murray C . Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72(3):429-45. PMC: 2486718. View

. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022; 10(3):177-192. PMC: 8860753. DOI: 10.1016/S2213-8587(21)00349-1. View

Liu W, Zhang D, Wang R, Chen J, Zhang J, Tao D . Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age-period-cohort analysis. Diabetes Obes Metab. 2023; 26(2):602-610. DOI: 10.1111/dom.15349. View

Ruiz-Ortega M, Rodrigues-Diez R, Lavoz C, Rayego-Mateos S . Special Issue "Diabetic Nephropathy: Diagnosis, Prevention and Treatment". J Clin Med. 2020; 9(3). PMC: 7141346. DOI: 10.3390/jcm9030813. View

Clements J, West B, Yaker Z, Lauinger B, McCullers D, Haubert J . Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race. Diabetes Res Clin Pract. 2019; 159:107984. PMC: 6959124. DOI: 10.1016/j.diabres.2019.107984. View

10.

Thomas B . The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps. Curr Diab Rep. 2019; 19(4):18. DOI: 10.1007/s11892-019-1133-6. View

11.

Golden S, Brown A, Cauley J, Chin M, Gary-Webb T, Kim C . Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012; 97(9):E1579-639. PMC: 3431576. DOI: 10.1210/jc.2012-2043. View

12.

Zhao G, Zhu S, Zhang F, Zhang X, Zhang X, Li T . Global Burden of osteoarthritis associated with high body mass index in 204 countries and territories, 1990-2019: findings from the Global Burden of Disease Study 2019. Endocrine. 2022; 79(1):60-71. DOI: 10.1007/s12020-022-03201-w. View

13.

Pan X, Lin X, Huang X, Xu J, Ye L, Zhang T . The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019. Front Endocrinol (Lausanne). 2022; 13:892860. PMC: 9240757. DOI: 10.3389/fendo.2022.892860. View

14.

Hu K, Ding P, Wu Y, Tian W, Pan T, Zhang S . Global patterns and trends in the breast cancer incidence and mortality according to sociodemographic indices: an observational study based on the global burden of diseases. BMJ Open. 2019; 9(10):e028461. PMC: 6797270. DOI: 10.1136/bmjopen-2018-028461. View

15.

Xie D, Ma T, Cui H, Li J, Zhang A, Sheng Z . Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years, 1990-2019. Sci Rep. 2023; 13(1):20234. PMC: 10658077. DOI: 10.1038/s41598-023-47091-y. View

16.

Teng T, Katzenellenbogen J, Thompson S, Sanfilippo F, Knuiman M, Geelhoed E . Incidence of first heart failure hospitalisation and mortality in Aboriginal and non-Aboriginal patients in Western Australia, 2000-2009. Int J Cardiol. 2014; 173(1):110-7. DOI: 10.1016/j.ijcard.2014.02.020. View

17.

. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018; 5(12):987-1012. PMC: 6251968. DOI: 10.1016/S2215-0366(18)30337-7. View

18.

Roderick P, Atkins R, Smeeth L, Mylne A, Nitsch D, Hubbard R . CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis. 2009; 53(6):950-60. DOI: 10.1053/j.ajkd.2008.12.036. View

19.

. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020; 98(4S):S1-S115. DOI: 10.1016/j.kint.2020.06.019. View

20.

Hill C, Cardwell C, Maxwell A, Young R, Matthews B, ODonoghue D . Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit. QJM. 2013; 106(10):933-42. DOI: 10.1093/qjmed/hct123. View